Drug Database
Back to search

France· FR:65001388

RUPATADINE VIATRIS 10 mg, comprimé

A rupatadin product containing fumarate de rupatadine, registered in France by VIATRIS SANTE, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC R06AX28

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedRUPATADINE VIATRIS 10 mg, compriméATCR06AX28REGISTER NO.FR:65001388PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fumarate de rupatadineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Rupatadin is registered in 13 of 19 countries.

Countries holding a registration under ATC R06AX28 (rupatadin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 8 of them publish a price we can compare per daily dose
Search rupatadin products by name

Rupatadin · ATC R06AX28

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rupatadin costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.12 in France to $0.40 in Spain — a ×3.4 gap.

  • France: $0.12 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Rupatadin · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • ES Spain$0.40
  • IT Italy$0.26
  • FR France$0.12
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
FUMARATE DE RUPATADINE
Manufacturer
VIATRIS SANTE
Country
France (FR)
ATC code
R06AX28
ATC class
Rupatadin
Defined daily dose
10 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400930077320
    plaquette(s) PVC PVDC aluminium de 15 comprimé(s)
    EUR 1.62
  • cip13
    3400930077344
    plaquette(s) PVC PVDC aluminium de 30 comprimé(s)
    EUR 2.88

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Rupatadin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rupatadin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Rupafin
  • Belgium · Rupatadine Eg, Rupatall
  • Bulgaria · Рупафин
  • Cyprus · Rupafin
  • Czechia · Tamalis
  • Germany · Rupafin, Rupatadin Al
  • Denmark · Rupafin
  • Estonia · Rupafin
  • Spain · Alergoliber, Rinialer
  • United Kingdom (Northern Ireland) · Rupatadine Aspire Pharma
  • Greece · Rupafin
  • Croatia · Rupafin
  • Hungary · Tamalis
  • Ireland · Rupafin
  • Iceland · Rupafin
  • Italy · Mostaxyl, Pafinur
  • Liechtenstein · Rupafin
  • Lithuania · Rupafin
  • Luxembourg · Rupatall
  • Latvia · Rupafin
  • Malta · Rinialer
  • Netherlands · Rupafin, Rupatadine Cf
  • Norway · Rupafin
  • Poland · Rupafin, Rupaller
  • Portugal · Rinialer, Rupatadina Bluefish
  • Romania · Tamalis
  • Sweden · Pafinur
  • Slovenia · Rupafin
  • Slovakia · Rupafin, Rupastad

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/edeb9ee5-59cc-4777-a88e-3d1484d3e979
GET /v1/drugs/edeb9ee5-59cc-4777-a88e-3d1484d3e979?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65001388",
  "date_amm": "2016-12-07",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "FUMARATE DE RUPATADINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about rupatadin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console